Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kanz

Showing results (131-140 of 241) with videos related to

Pageof 25
Sort By:
Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.
Clinical Rheumatology|May 16, 2007
Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomideJ C Henes, J Fritz, S Koch, et al.
The Journal of Rheumatology|February 24, 2000
Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: a pilot studyI Günaydin, P L Pereira, T Daikeler, et al.
British Journal of Haematology|September 21, 2000
Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemiaR Möhle, M Schittenhelm, C Failenschmid, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Cancer Research|September 2, 2000
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
British Journal of Cancer|October 29, 2002
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancerC Bokemeyer, K Oechsle, J T Hartmann, et al.
Pageof 25

Showing results (131-140 of 241) with videos related to

Sort By:
Pageof 25
Seminars in Oncology|January 14, 1998
Paclitaxel and weekly 24-hour infusion of 5-fluorouracil/folinic acid in advanced gastric cancerC Bokemeyer, J T Hartmann, C S Lampe, et al.
Clinical Rheumatology|May 16, 2007
Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomideJ C Henes, J Fritz, S Koch, et al.
The Journal of Rheumatology|February 24, 2000
Magnetic resonance imaging guided corticosteroid injection of the sacroiliac joints in patients with therapy resistant spondyloarthropathy: a pilot studyI Günaydin, P L Pereira, T Daikeler, et al.
British Journal of Haematology|September 21, 2000
Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemiaR Möhle, M Schittenhelm, C Failenschmid, et al.
Anti-Cancer Drugs|April 11, 2000
The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumorsJ T Hartmann, S Knop, L M Fels, et al.
Investigational New Drugs|September 1, 2005
An open label, non-comparative phase II study of gemcitabine as salvage treatment for patients with pretreated adult type soft tissue sarcomaJ T Hartmann, K Oechsle, J Huober, et al.
Cancer Research|September 2, 2000
Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cellsP Brossart, A Zobywalski, F Grünebach, et al.
Anti-Cancer Drugs|July 11, 1998
Phase II study of continuous 120 h infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent colorectal cancerJ T Hartmann, A Harstrick, T Daikeler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
Treatment of clinical stage I testicular cancer and a possible role for new biological prognostic parametersC Bokemeyer, M A Kuczyk, J Serth, et al.
British Journal of Cancer|October 29, 2002
Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancerC Bokemeyer, K Oechsle, J T Hartmann, et al.
Pageof 25